2005-03-02 - Male
180204
| Adverse reaction report number | 180204 |
| Latest AER version number | 0 |
| Market authorization holder AER number | N/A |
| Initial received date | 2005-03-02 |
| Latest received date | 2005-03-02 |
| Age | N/A |
| Gender | Male |
| Weight | N/A |
| Type of report | Spontaneous |
| Reporter type | Consumer Or Other Non Health Professional |
| Source of report | Community |
| Report outcome | Unknown |
| Serious report? | No |
| Product description | Dosage form | Health product role | Route of administration | Dose | Frequency | Therapy duration | Indication(s) |
|---|---|---|---|---|---|---|---|
| ADDERALL XR | CAPSULE, EXTENDED RELEASE | Suspect | Oral | 30 Milligram | 1 every 1 Day(s) | 1 Year(s) | |
| ASACOL | TABLET (ENTERIC-COATED) | Concomitant | |||||
| CELEXA | TABLET | Concomitant | Oral |
| MedDRA version: v.21.1 | |
| Adverse reaction terms | Reaction duration |
|---|---|
| Blood urine present | |
| Epistaxis | |
| Headache | |
| Heart rate increased | |
| Hot flush | |
| Hyperhidrosis | |
| Vision blurred | |